abstract |
The invention relates to the use of 1-phenyl-1,2-diaminoethane derivatives of formula (I) n n n n n n n n n n wherein the groups A, R 1 , R 2 and R a through R j have the meanings given in the claims and specification, for the preparation of a medicament for the treatment and/or prevention of a disease, wherein the activity of a CCR3 receptor is involved and to novel compounds of formula (I), wherein A represents —CH 2 CH 2 — or —C(═O)—NH—. |